Answers are grounded in this paper and cite their sources.
Progestin-based therapy can safely be offered to a subset of patients with atypical endometrial hyperplasia or Grade 1 endometrioid endometrial cancer who desire fertility preservation. A recent study shows that levonorgestrel intrauterine device confers durable clinical benefit and identifies possible immune mechanisms of relapse and resistance.
No takes yet. Share an insight, caveat, or question.
Johannet et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: